Molecular mechanism of the ichthyosis pathology of Chanarin-Dorfman syndrome: Stimulation of PNPLA1-catalyzed ω-O-acylceramide production by ABHD5

被引:40
|
作者
Ohno, Yusuke [1 ]
Nara, Atsuki [2 ]
Nakamichi, Shota [1 ]
Kihara, Akio [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Sapporo, Hokkaido 0600812, Japan
[2] Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama 5260829, Japan
基金
日本学术振兴会;
关键词
Acylceramide; Chanarin-Dorfman syndrome; Ichthyosis; Lipid; Lipid droplet; PERMEABILITY BARRIER; LIPID DROPLETS; CGI-58; MUTATIONS; UPDATE; GROWTH;
D O I
10.1016/j.jdermsci.2018.11.005
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: ABHD5 mutations cause Chanarin-Dorfman syndrome accompanied by ichthyosis. omega-O-Acylceramide (acylceramide) is essential for skin permeability barrier formation. Acylceramide production is impaired in Abhd5 knockout mice. The transacylase PNPLA1 catalyzes the final step of acylceramide production: transfer of linoleic acid in triglyceride to omega-hydroxyceramide. Objective: We aimed to elucidate the role of ABHD5 in acylceramide production and the molecular mechanism of the ichthyosis symptoms of Chanarin-Dorfman syndrome. Methods: We investigated how ABHD5 influences acylceramide production using an acylceramide-producing cell system. The effects of ABHD5 and PNPLA1 expression on the morphology of lipid droplets were examined by indirect immunofluorescent microscopy and immunoelectron microscopy. Results: When ABHD5 was expressed in the acylceramide-producing cell system, acylceramide synthesis by PNPLA1 was enhanced. Dispersed localization of PNPLAI was observed by immunofluorescent microscopy in HeLa cells under lipid droplet-forming conditions. Co-expression with ABHD5 caused PNPLA1 to localize on the lipid droplet membranes or their periphery. This staining pattern was observed in cells where PNPLAI and ABHD5 were expressed at low levels. In contrast, lipid droplets disappeared in cells where PNPLA1 and ABHD5 were highly expressed. lmmunoelectron microscopic analyses suggested that lipid droplets underwent morphological changes, transforming into vesicles or becoming incorporated into the endoplasmic reticulum. ABHD5 mutations found in Chanarin-Dorfman syndrome patients reduced ABHD5's ability to promote PNPLA1-dependent acylceramide production. Conclusion: ABHD5 enhances PNPLA1-catalyzed acylceramide production. We speculate that ABHD5 retains triglycerides in the endoplasmic reticulum, and presents them to PNPLA1 to promote substrate recognition. (C) 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 3 条
  • [1] ABHD5 stimulates PNPLA1-mediated ω-O-acylceramide biosynthesis essential for a functional skin permeability barrier
    Kien, Benedikt
    Grond, Susanne
    Haemmerle, Guenter
    Lass, Achim
    Eichmann, Thomas O.
    Radner, Franz P. W.
    JOURNAL OF LIPID RESEARCH, 2018, 59 (12) : 2360 - 2367
  • [2] Molecular analysis of Chanarin-Dorfman syndrome (CDS) patients: Identification of novel mutations in the ABHD5 gene
    Emre, Serap
    Unver, Nese
    Evans, Sibel Ersoy
    Yuzbasioglu, Ayse
    Gurakan, Figen
    Gumruk, Fatma
    Karaduman, Aysen
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2010, 53 (03) : 141 - 144
  • [3] ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production
    Vieyres, Gabrielle
    Welsch, Kathrin
    Gerold, Gisa
    Gentzsch, Juliane
    Kahl, Sina
    Vondran, Florian W. R.
    Kaderali, Lars
    Pietschmann, Thomas
    PLOS PATHOGENS, 2016, 12 (04)